Related Experiment Videos
Isolation and preliminary characterization of Streptococcus cremoris (strain 202) bacteriocin
Summary
Streptococcus cremoris strain 202 produces a unique bacteriocin, lactostrepcin, effective against various bacteria. Its production mechanism, potentially plasmid-linked, requires further investigation in this and its variants.
Area of Science:
- Microbiology
- Bacteriocins
- Streptococcus cremoris
Background:
- Bacteriocins are antimicrobial peptides with significant biotechnological potential.
- Streptococcus cremoris is a key species in dairy fermentations.
- Limited information exists on bacteriocin production within S. cremoris strains.
Purpose of the Study:
- To investigate the bacteriocin-producing capabilities of Streptococcus cremoris strains.
- To characterize a novel bacteriocin, lactostrepcin, produced by S. cremoris strain 202.
- To explore the genetic basis of lactostrepcin production.
Main Methods:
- Screening of 17 S. cremoris strains for bacteriocin production.
- Preliminary characterization of the bacteriocin's activity spectrum.
- Plasmid profiling of the producing strain and its variants.
Main Results:
- Only one of 17 S. cremoris strains (strain 202) produced bacteriocin (lactostrepcin).
- Lactostrepcin exhibited activity against lactic streptococci, Bacillus cereus, Leuconostoc, and Lactobacillus species.
- Strain 202 harbored plasmids, but their direct role in lactostrepcin production was not confirmed.
- Plasmid patterns of lactostrepcin-negative variants could be altered or unchanged compared to the parent strain.
Conclusions:
- Streptococcus cremoris strain 202 produces a distinct bacteriocin, lactostrepcin.
- Lactostrepcin possesses a broad antimicrobial spectrum, suggesting potential applications.
- The genetic determinants for lactostrepcin production may be plasmid-located, but this requires further validation.